The Petri Dish: ADHD-treating videogame cleared for teens, CRISPR exec resigns

Just six days after her company’s landmark sickle-cell drug was approved in the U.S., CRISPR Therapeutics’ chief medical officer resigned. Plus, other life sciences news you may have missed.